IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.
1] Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland. [2].
Stephan
S
von Gunten
1] Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 5262225, Israel. Yehuda Shoenfeld is also at the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, Tel Aviv 5262225, Israel. [2].
Yehuda
Y
Shoenfeld
1] Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 5262225, Israel. Yehuda Shoenfeld is also at the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, Tel Aviv 5262225, Israel. [2].
Miri
M
Blank
1] Department of Medicine, University of Toronto, and Centre for Innovation, Canadian Blood Services, Toronto, Ontario M5G 2M1, Canada. [2].
Donald R
DR
Branch
1] Department of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria. [2].
Tchavdar
T
Vassilev
1] Research and Development, CSL Behring AG, CH-3000 Bern, Switzerland. [2].
Fabian
F
Käsermann
1] Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Pierre et Marie Curie, Paris 6, Centre de Recherche des Cordeliers, 75006 Paris, France. [2].
Jagadeesh
J
Bayry
1] Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Pierre et Marie Curie, Paris 6, Centre de Recherche des Cordeliers, 75006 Paris, France. [2].
Srini
S
Kaveri
1] Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland. [2].
Hans-Uwe
HU
Simon
D000818:Animals; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D056747:Immunomodulation / Q000187:drug effects*; D007165:Immunosuppression Therapy
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous